{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:02:47Z","timestamp":1772121767796,"version":"3.50.1"},"reference-count":170,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"am","delay-in-days":290,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["2019\/05957-8"],"award-info":[{"award-number":["2019\/05957-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["302500\/2022-7"],"award-info":[{"award-number":["302500\/2022-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K25AG083057"],"award-info":[{"award-number":["K25AG083057"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS127211"],"award-info":[{"award-number":["R21NS127211"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS118146"],"award-info":[{"award-number":["R01NS118146"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["17\/21155-3"],"award-info":[{"award-number":["17\/21155-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005639","name":"Universidade de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005639","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy &amp; Behavior"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.yebeh.2025.110421","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T17:01:15Z","timestamp":1744909275000},"page":"110421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Transcriptomic analyses of human brains with Alzheimer\u2019s disease identified dysregulated epilepsy-causing genes"],"prefix":"10.1016","volume":"168","author":[{"given":"Abdallah M.","family":"Eteleeb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su\u00e9len Santos","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Buss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mouhsin","family":"Shafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Press","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norberto","family":"Garcia-Cairasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno A.","family":"Benitez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.yebeh.2025.110421_b0005","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/brain\/awac033","article-title":"Towards a coherent view of network hyperexcitability in Alzheimer\u2019s disease","volume":"145","author":"Lam","year":"2022","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110421_b0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1474-4422(17)30044-3","article-title":"Epileptic activity in Alzheimer\u2019s disease: causes and clinical relevance","volume":"16","author":"Vossel","year":"2017","journal-title":"The Lancet Neurology"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110421_b0015","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/epi.17186","article-title":"Seizure activity triggers tau hyperphosphorylation and amyloidogenic pathways","volume":"63","author":"Canet","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110421_b0020","article-title":"Bi-directional associations of epilepsy with dementia and Alzheimer\u2019s disease: a systematic review and meta-analysis of longitudinal studies","volume":"51(3):afac010","author":"Dun","year":"2022","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110421_b0025","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/epi.17494","article-title":"The epidemiology of epilepsy in older adults: A narrative review by the ILAE Task Force on Epilepsy in the Elderly","volume":"64","author":"Beghi","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110421_b0030","doi-asserted-by":"crossref","unstructured":"Fang Y, Si X, Wang J, Wang Z, Chen Y, Liu Y, et al. Alzheimer Disease and Epilepsy: A Mendelian Randomization Study. Neurology [Internet]. 2023 Jul 25 [cited 2024 Nov 7];101(4). Available from: https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0000000000207423.","DOI":"10.1212\/WNL.0000000000207423"},{"key":"10.1016\/j.yebeh.2025.110421_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2024.109723","article-title":"Bidirectional relationship between late-onset epilepsy (LOE) and dementia: A systematic review and meta-analysis of cohort studies","volume":"153","author":"Tan","year":"2024","journal-title":"Epilepsy Behav"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110421_b0040","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1002\/alz.12943","article-title":"Does Alzheimer\u2019s disease with mesial temporal lobe epilepsy represent a distinct disease subtype?","volume":"19","author":"Zawar","year":"2023","journal-title":"Alzheimer\u2019s & Dementia."},{"key":"10.1016\/j.yebeh.2025.110421_b0045","article-title":"The clinical correlation between Alzheimer\u2019s disease and epilepsy","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/epd2.20057","article-title":"Cognitive impairment as a comorbidity of epilepsy in older adults: Analysis of global and domain\u2010specific cognition","volume":"25","author":"Chai","year":"2023","journal-title":"Epileptic Disord"},{"issue":"5","key":"10.1016\/j.yebeh.2025.110421_b0055","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/jamaneurol.2023.0339","article-title":"Association of dementia risk with focal epilepsy and modifiable cardiovascular risk factors","volume":"80","author":"Tai","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2025.110421_b0060","doi-asserted-by":"crossref","unstructured":"Zawar I, Quigg M, Ghosal S, Punia V, Calle\u2010Lopez Y, Manning C, et al. Association of Seizure Control with Mortality, Cognition, and Function in People With Dementia. Annals of Neurology. 2024 Oct 30;ana.27125.","DOI":"10.1002\/ana.27125"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110421_b0065","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/epi.13744","article-title":"The association between dementia and epilepsy: A systematic review and meta\u2010analysis","volume":"58","author":"Subota","year":"2017","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110421_b0070","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/epi4.12744","article-title":"Assessment of tau phosphorylation and \u03b2\u2010amyloid pathology in human drug\u2010resistant epilepsy","volume":"8","author":"Aroor","year":"2023","journal-title":"Epilepsia Open"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0075","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/brain\/awz381","article-title":"Alzheimer-like amyloid and tau alterations associated with cognitive deficit in temporal lobe epilepsy","volume":"143","author":"Gourmaud","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2025.110421_b0080","doi-asserted-by":"crossref","unstructured":"A Bennett D, A Schneider J, Arvanitakis Z, S Wilson R. Overview and findings from the religious orders study. Current Alzheimer Research. 2012;9(6):628\u201345.","DOI":"10.2174\/156720512801322573"},{"issue":"8","key":"10.1016\/j.yebeh.2025.110421_b0085","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41582-021-00505-9","article-title":"Amyloid-\u03b2: a potential link between epilepsy and cognitive decline","volume":"17","author":"Romoli","year":"2021","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110421_b0090","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1007\/s12035-022-02810-w","article-title":"A genetic model of epilepsy with a partial alzheimer\u2019s disease-like phenotype and central insulin resistance","volume":"59","author":"Alves","year":"2022","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.yebeh.2025.110421_b0095","doi-asserted-by":"crossref","unstructured":"Alves SS, De Oliveira JAC, Lazarini-Lopes W, Servilha-Menezes G, Grig\u00f3rio-de-Sant\u2019Ana M, Del Vecchio F, et al. Audiogenic Seizures in the Streptozotocin-Induced Rat Alzheimer\u2019s Disease Model. JAD. 2023 Aug 1;94(3):1179\u201396.","DOI":"10.3233\/JAD-230153"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00401-024-02683-4","article-title":"Similar brain proteomic signatures in Alzheimer\u2019s disease and epilepsy","volume":"147","author":"Leitner","year":"2024","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.yebeh.2025.110421_b0105","doi-asserted-by":"crossref","unstructured":"Eid T, Gruenbaum SE, Dhaher R, Lee TSW, Zhou Y, Danbolt NC. The Glutamate\u2013Glutamine Cycle in Epilepsy. In: Schousboe A, Sonnewald U, editors. The Glutamate\/GABA-Glutamine Cycle [Internet]. Cham: Springer International Publishing; 2016 [cited 2024 Nov 7]. p. 351\u2013400. (Advances in Neurobiology; vol. 13). Available from: http:\/\/link.springer.com\/10.1007\/978-3-319-45096-4_14.","DOI":"10.1007\/978-3-319-45096-4_14"},{"issue":"7\u20138","key":"10.1016\/j.yebeh.2025.110421_b0110","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.neuint.2006.10.007","article-title":"Glutamate\u2013glutamine cycling in Alzheimer\u2019s disease","volume":"50","author":"Walton","year":"2007","journal-title":"Neurochem Int"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0115","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11845-023-03447-x","article-title":"Identification of common core ion channel genes in epilepsy and Alzheimer\u2019s disease","volume":"193","author":"Tang","year":"2024","journal-title":"Ir J Med Sci"},{"issue":"s1","key":"10.1016\/j.yebeh.2025.110421_b0120","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-230059","article-title":"Neuroinflammation: A common pathway in Alzheimer\u2019s disease and epilepsy","volume":"94","author":"Liew","year":"2023","journal-title":"J Alzheimer\u2019s Disease"},{"key":"10.1016\/j.yebeh.2025.110421_b0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.brainresbull.2020.04.009","article-title":"Epilepsy and Alzheimer\u2019s Disease: Potential mechanisms for an association","volume":"160","author":"Giorgi","year":"2020","journal-title":"Brain Res Bull"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110421_b0130","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3390\/biomedicines11041108","article-title":"Do epilepsy patients with cognitive impairment have alzheimer\u2019s disease-like brain metabolism?","volume":"11","author":"He","year":"2023","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110421_b0135","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41582-022-00651-8","article-title":"The metabolic basis of epilepsy","volume":"18","author":"Rho","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.yebeh.2025.110421_b0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yebeh.2019.06.015","article-title":"Association of apolipoprotein E genotypes with epilepsy risk: A systematic review and meta-analysis","volume":"98","author":"Liang","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110421_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002607","article-title":"Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer\u2019s disease","volume":"22","author":"Eteleeb","year":"2024","journal-title":"PLoS Biol"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sdata.2018.185","article-title":"The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer\u2019s disease","volume":"5","author":"Wang","year":"2018","journal-title":"Sci Data"},{"key":"10.1016\/j.yebeh.2025.110421_b0155","series-title":"FastQC: a quality control tool for high throughput sequence data","author":"Andrews","year":"2010"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.yebeh.2025.110421_b0165","unstructured":"Picard Toolkit.\u201d 2019. Broad Institute, GitHub Repository. https:\/\/broadinstitute.github.io\/picard\/; Broad Institute."},{"issue":"16","key":"10.1016\/j.yebeh.2025.110421_b0170","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1093\/bioinformatics\/bts356","article-title":"RSeQC: quality control of RNA-seq experiments","volume":"28","author":"Wang","year":"2012","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0175","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12859-016-0922-z","article-title":"Measure transcript integrity using RNA-seq data","volume":"17","author":"Wang","year":"2016","journal-title":"BMC Bioinf"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/biostatistics\/kxx017","article-title":"A fully Bayesian latent variable model for integrative clustering analysis of multi-type omics data","volume":"19","author":"Mo","year":"2018","journal-title":"Biostatistics"},{"key":"10.1016\/j.yebeh.2025.110421_b0185","doi-asserted-by":"crossref","unstructured":"Mo Q, Shen R. iClusterPlus: integrative clustering of multiple genomic data sets. 2013.","DOI":"10.1214\/12-AOAS578"},{"issue":"12","key":"10.1016\/j.yebeh.2025.110421_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.yebeh.2025.110421_bib846","unstructured":"Jawaid W. enrichR: Provides an R Interface to \u201cEnrichr\u201d. R package version 3.0. Available from: https:\/\/CRAN.R-project.org\/package=enrichR; 2021."},{"key":"10.1016\/j.yebeh.2025.110421_b0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.seizure.2016.11.030","article-title":"Epilepsy-associated genes","volume":"44","author":"Wang","year":"2017","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","article-title":"Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse","volume":"89","author":"Zhang","year":"2016","journal-title":"Neuron"},{"issue":"7991","key":"10.1016\/j.yebeh.2025.110421_b0205","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41586-023-06812-z","article-title":"A high-resolution transcriptomic and spatial atlas of cell types in the whole mouse brain","volume":"624","author":"Yao","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.yebeh.2025.110421_b0210","article-title":"Integrated multimodal cell atlas of Alzheimer\u2019s disease","volume":"1\u201318","author":"Gabitto","year":"2024","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.yebeh.2025.110421_b0215","article-title":"SEA-AD is a multimodal cellular atlas and resource for Alzheimer\u2019s disease","volume":"1\u20134","author":"Hawrylycz","year":"2024","journal-title":"Nat Aging"},{"key":"10.1016\/j.yebeh.2025.110421_b0220","unstructured":"Dataset: Allen Institute for Brain Science, University of Washington Alzheimer\u2019s Disease Research Center, and Kaiser Permanente Washington Health Research Institute (2022). Seattle Alzheimer\u2019s Disease Brain Cell Atlas (SEA-AD) -- Donor Metadata and Neuropathology [dataset]. Available from https:\/\/knowledge.brain-map.org\/data\/JGN327NUXRZSHEV88TN\/donors."},{"issue":"2","key":"10.1016\/j.yebeh.2025.110421_b0225","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24170","article-title":"Impairment of ceramide synthesis causes a novel progressive myoclonus epilepsy","volume":"76","author":"Vanni","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.yebeh.2025.110421_b0230","article-title":"Progressive myoclonic epilepsy type 8 due to CERS1 deficiency: a novel mutation with prominent ataxia","volume":"5(3):330","author":"De Junior","year":"2018","journal-title":"Movement disorders clinical practice"},{"issue":"03","key":"10.1016\/j.yebeh.2025.110421_b0235","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1055\/s-0035-1552620","volume":"35","author":"Progressive","year":"2015","journal-title":"Semin Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0725","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s42494-023-00139-y","article-title":"Developmental and epileptic encephalopathy 44 due to compound heterozygous variants in the UBA5 gene: a case report","volume":"5","author":"Zhang","year":"2023","journal-title":"Acta Epileptologica"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0730","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12881-017-0466-8","article-title":"Compound heterozygous mutations in UBA5 causing early-onset epileptic encephalopathy in two sisters","volume":"18","author":"Arnadottir","year":"2017","journal-title":"BMC Med Genet"},{"issue":"7","key":"10.1016\/j.yebeh.2025.110421_b0735","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/humu.23534","article-title":"Abnormal function of the UBA5 protein in a case of early developmental and epileptic encephalopathy with suppression-burst","volume":"39","author":"Mignon-Ravix","year":"2018","journal-title":"Hum Mutat"},{"issue":"03","key":"10.1016\/j.yebeh.2025.110421_b0525","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-0041-1727099","article-title":"The Spectrum of KCNQ2- and KCNQ3-Related Epilepsy","volume":"21","author":"Portale","year":"2023","journal-title":"J Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2025.110421_b0740","unstructured":"Miceli F, Soldovieri MV, Weckhuysen S, Cooper E, Taglialatela M. KCNQ2-related disorders. 2022 [cited 2024 Apr 16]; Available from: https:\/\/europepmc.org\/article\/nbk\/nbk32534."},{"issue":"3","key":"10.1016\/j.yebeh.2025.110421_b0745","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/01.wnl.0000317090.92185.ec","article-title":"KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes","volume":"71","author":"Neubauer","year":"2008","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.yebeh.2025.110421_b0565","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1073\/pnas.251485198","article-title":"Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice","volume":"98","author":"Gupta","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.yebeh.2025.110421_b0575","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.3390\/ijms23105586","article-title":"Seizures in PPT1 knock-in mice are associated with inflammatory activation of microglia","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110421_b0750","first-page":"199","article-title":"Epilepsy in neuronal ceroid lipofuscinoses","volume":"3","author":"Kohlsch\u00fctter","year":"2014","journal-title":"Journal of Pediatric Epilepsy"},{"issue":"5","key":"10.1016\/j.yebeh.2025.110421_b0755","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ejmg.2012.04.002","article-title":"Molecular bases and clinical spectrum of early infantile epileptic encephalopathies","volume":"55","author":"Asher","year":"2012","journal-title":"Eur J Med Genet"},{"issue":"16","key":"10.1016\/j.yebeh.2025.110421_b0760","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1093\/hmg\/ddl174","article-title":"A GABRB3 promoter haplotype associated with childhood absence epilepsy impairs transcriptional activity","volume":"15","author":"Urak","year":"2006","journal-title":"Hum Mol Genet"},{"issue":"15","key":"10.1016\/j.yebeh.2025.110421_b0765","doi-asserted-by":"crossref","first-page":"12083","DOI":"10.1074\/jbc.M111.332528","article-title":"GABRB3 mutation, G32R, associated with childhood absence epilepsy alters \u03b11\u03b23\u03b32L \u03b3-aminobutyric acid type A (GABAA) receptor expression and channel gating","volume":"287","author":"Gurba","year":"2012","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110421_b0770","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/dmcn.12976","article-title":"GABRB3 mutations: a new and emerging cause of early infantile epileptic encephalopathy","volume":"58","author":"Papandreou","year":"2016","journal-title":"Develop Med Child Neuro"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110421_b0775","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/ana.24580","article-title":"Benign infantile seizures and paroxysmal dyskinesia caused by an SCN8A mutation","volume":"79","author":"Gardella","year":"2016","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110421_b0780","doi-asserted-by":"crossref","first-page":"147","DOI":"10.14581\/jer.19017","article-title":"SCN8A mutation in infantile epileptic encephalopathy: report of two cases","volume":"9","author":"Fatema","year":"2019","journal-title":"J Epilepsy Research"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110421_b0340","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ng.2952","article-title":"De novo mutations in HCN1 cause early infantile epileptic encephalopathy","volume":"46","author":"Nava","year":"2014","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.yebeh.2025.110421_b0785","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3923\/pjbs.2020.973.976","article-title":"A novel nonsense gene variant responsible for early infantile epileptic encephalopathy type 39: Case report","volume":"23","author":"Saleh","year":"2020","journal-title":"Pakistan J Bio Sci: PJBS"},{"key":"10.1016\/j.yebeh.2025.110421_b0790","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.seizure.2019.04.018","article-title":"The landscape of early infantile epileptic encephalopathy in a consanguineous population","volume":"69","author":"Nashabat","year":"2019","journal-title":"Seizure"},{"issue":"8","key":"10.1016\/j.yebeh.2025.110421_b0465","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1111\/ene.15424","article-title":"Early infantile epileptic encephalopathy related to NECAP1 : Clinical delineation of the disease and review","volume":"29","author":"Chouery","year":"2022","journal-title":"Euro J of Neurology"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110421_b0795","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.yebeh.2011.11.022","article-title":"SCN1A mutations in Dravet syndrome: impact of interneuron dysfunction on neural networks and cognitive outcome","volume":"23","author":"Bender","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2025.110421_b0800","unstructured":"Miller IO, Sotero de Menezes MA. SCN1A seizure disorders. 2022 [cited 2024 Apr 18]; Available from: https:\/\/europepmc.org\/article\/nbk\/nbk1318?client=bot&client=bot&client=bot&client=bot&client=bot."},{"key":"10.1016\/j.yebeh.2025.110421_b0805","unstructured":"Myers KA, Scheffer IE. GRIN2A-related speech disorders and epilepsy. 2016 [cited 2024 Apr 18]; Available from: https:\/\/europepmc.org\/article\/nbk\/nbk385627."},{"issue":"10","key":"10.1016\/j.yebeh.2025.110421_b0810","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrneurol.2013.181","article-title":"GRIN2A mutations identified as key genetic drivers of epilepsy\u2013aphasia spectrum disorders","volume":"9","author":"Kingwell","year":"2013","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110421_b0815","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/humu.21253","article-title":"Mutations in MEF2C from the 5q14.3q15 microdeletion syndrome region are a frequent cause of severe mental retardation and diminish MECP2 and CDKL5 expression","volume":"31","author":"Zweier","year":"2010","journal-title":"Hum Mutat"},{"issue":"5","key":"10.1016\/j.yebeh.2025.110421_b0820","doi-asserted-by":"crossref","first-page":"e494","DOI":"10.1212\/NXG.0000000000000494","article-title":"Childhood-onset epileptic encephalopathy due to FGF12 exon 1\u20134 tandem duplication","volume":"6","author":"Verheyen","year":"2020","journal-title":"Neurol Genet"},{"issue":"8","key":"10.1016\/j.yebeh.2025.110421_b0825","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.braindev.2021.04.010","article-title":"Effective treatments for FGF12-related early-onset epileptic encephalopathies patients","volume":"43","author":"Tian","year":"2021","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2025.110421_b0830","article-title":"Clinical phenotype and genotype of children with GABAA receptor \u03b11 subunit gene-related epilepsy","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110421_b0835","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/ana.20874","article-title":"A mutation in the GABA A receptor \u03b1 1 \u2010subunit is associated with absence epilepsy","volume":"59","author":"Maljevic","year":"2006","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110421_b0840","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ng885","article-title":"Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy","volume":"31","author":"Cossette","year":"2002","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.yebeh.2025.110421_b0335","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/jamaneurol.2016.0449","article-title":"Molecular pathogenic basis for GABRG2 mutations associated with a spectrum of epilepsy syndromes, from generalized absence epilepsy to Dravet syndrome","volume":"73","author":"Kang","year":"2016","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110421_b0845","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/biom13030414","article-title":"GABRG2 Variants associated with febrile seizures","volume":"13","author":"Hernandez","year":"2023","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110421_b0240","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3390\/biomedicines11030783","article-title":"The role of glutamate receptors in epilepsy","volume":"11","author":"Chen","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.yebeh.2025.110421_b0245","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fncel.2013.00157","article-title":"The role of dopamine signaling in epileptogenesis","volume":"7","author":"Bozzi","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.yebeh.2025.110421_b0250","article-title":"The role of dopaminergic and serotonergic systems in neurodevelopmental disorders: a focus on epilepsy and seizure susceptibility","volume":"5(2):97","author":"Tripathi","year":"2015","journal-title":"Bioimpacts"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0255","first-page":"1","article-title":"Epilepsy and dopaminergic system","volume":"21","author":"Rezaei","year":"2017","journal-title":"Physiol Pharmacol"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110421_b0260","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1098-2396(199602)22:2<159::AID-SYN8>3.0.CO;2-C","article-title":"The role of dopamine in epilepsy","volume":"22","author":"Starr","year":"1996","journal-title":"Synapse"},{"issue":"s3","key":"10.1016\/j.yebeh.2025.110421_b0265","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1528-1157.2001.042suppl.3008.x","article-title":"GABAergic mechanisms in epilepsy","volume":"42","author":"Treiman","year":"2001","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.yebeh.2025.110421_b0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0288120","article-title":"How do smoking, vaping, and nicotine affect people with epilepsy and seizures? A scoping review protocol","volume":"18","author":"Narrett","year":"2023","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110421_b0275","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.yebeh.2008.04.003","article-title":"Exercise, diet, health behaviors, and risk factors among persons with epilepsy based on the California Health Interview Survey, 2005","volume":"13","author":"Elliott","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2025.110421_b0280","series-title":"MMWR Morbidity and Mortality Weekly Report [Internet]","article-title":"Prevalence and trends in cigarette smoking among adults with epilepsy\u2014United States","author":"Sapkota","year":"2010"},{"issue":"11","key":"10.1016\/j.yebeh.2025.110421_b0285","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fneur.2020.00327","article-title":"Epilepsy and its interaction with sleep and circadian rhythm","volume":"8","author":"Jin","year":"2020","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110421_b0290","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022814","article-title":"Role of sodium channels in epilepsy","volume":"6","author":"Kaplan","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.yebeh.2025.110421_b0295","unstructured":"Cain SM, Snutch TP. Voltage-gated calcium channels in epilepsy. Jasper\u2019s Basic Mechanisms of the Epilepsies [Internet] 4th edition [Internet]. 2012 [cited 2024 Apr 19]; Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK98147\/."},{"issue":"11","key":"10.1016\/j.yebeh.2025.110421_b0300","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3389\/fphar.2020.01276","article-title":"Epilepsy-related voltage-gated sodium channelopathies: A review","volume":"18","author":"Menezes","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0305","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s42494-023-00127-2","article-title":"Therapeutic efficacy of voltage-gated sodium channel inhibitors in epilepsy","volume":"5","author":"Agbo","year":"2023","journal-title":"Acta Epileptologica"},{"issue":"7","key":"10.1016\/j.yebeh.2025.110421_b0310","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/dmcn.14519","article-title":"Sodium channel epilepsies and neurodevelopmental disorders: from disease mechanisms to clinical application","volume":"62","author":"Brunklaus","year":"2020","journal-title":"Develop Med Child Neuro"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110421_b0315","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1684\/epd.2022.1444","article-title":"Epilepsy in patients with WWOX \u2010related epileptic encephalopathy (WOREE) syndrome","volume":"24","author":"Al Baradie","year":"2022","journal-title":"Epileptic Disord"},{"issue":"5","key":"10.1016\/j.yebeh.2025.110421_b0320","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/epi.17542","article-title":"WWOX developmental and epileptic encephalopathy: Understanding the epileptology and the mortality risk","volume":"64","author":"Oliver","year":"2023","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.yebeh.2025.110421_b0325","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1093\/brain\/awab174","article-title":"Neuronal deletion of Wwox, associated with WOREE syndrome, causes epilepsy and myelin defects","volume":"144","author":"Repudi","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2025.110421_b0330","doi-asserted-by":"crossref","unstructured":"Cheng YY, Chou YT, Lai FJ, Jan MS, Chang TH, Jou IM, et al. Wwox deficiency leads to neurodevelopmental and degenerative neuropathies and glycogen synthase kinase 3\u03b2-mediated epileptic seizure activity in mice. acta neuropathol commun. 2020 Dec;8(1):6.","DOI":"10.1186\/s40478-020-0883-3"},{"key":"10.1016\/j.yebeh.2025.110421_b0345","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.870182","article-title":"Novel HCN1 mutations associated with epilepsy and impacts on neuronal excitability","volume":"15","author":"Xie","year":"2022","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0350","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1124\/pr.117.014456","article-title":"Ion channels in genetic epilepsy: from genes and mechanisms to disease-targeted therapies","volume":"70","author":"Oyrer","year":"2018","journal-title":"Pharmacol Rev"},{"issue":"5","key":"10.1016\/j.yebeh.2025.110421_b0355","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ajhg.2008.10.003","article-title":"A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome","volume":"83","author":"Bassuk","year":"2008","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/j.yebeh.2025.110421_b0360","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1002\/ajmg.a.40625","article-title":"PRICKLE1 \u2010related early onset epileptic encephalopathy","volume":"176","author":"Mastrangelo","year":"2018","journal-title":"Am J Med Genetics Pt A"},{"issue":"11","key":"10.1016\/j.yebeh.2025.110421_b0365","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/nm.4413","article-title":"Epigenetic suppression of hippocampal calbindin-D28k by \u0394FosB drives seizure-related cognitive deficits","volume":"23","author":"You","year":"2017","journal-title":"Nat Med"},{"issue":"18","key":"10.1016\/j.yebeh.2025.110421_b0370","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.15252\/embj.201488143","article-title":"A conformational switch in collybistin determines the differentiation of inhibitory postsynapses","volume":"33","author":"Soykan","year":"2014","journal-title":"EMBO J"},{"issue":"7","key":"10.1016\/j.yebeh.2025.110421_b0375","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.3390\/ijms25074110","article-title":"X-linked epilepsies: A narrative review","volume":"25","author":"Bernardo","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.yebeh.2025.110421_b0380","doi-asserted-by":"crossref","first-page":"e1967","DOI":"10.1002\/mgg3.1967","article-title":"ARHGEF9 gene variant leads to developmental and epileptic encephalopathy: Genotypic phenotype analysis and treatment exploration","volume":"10","author":"Yang","year":"2022","journal-title":"Molec Gen & Gen Med"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110421_b0385","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s12031-019-01465-y","article-title":"Clinical and molecular characterization of three novel ARHGEF9 mutations in patients with developmental delay and epilepsy","volume":"70","author":"Yao","year":"2020","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.yebeh.2025.110421_b0390","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnagi.2016.00031","article-title":"Implications of GABAergic neurotransmission in Alzheimer\u2019s disease","volume":"8","author":"Li","year":"2016","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0395","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12964-024-01528-7","article-title":"Impairments of GABAergic transmission in hippocampus mediate increased susceptibility of epilepsy in the early stage of Alzheimer\u2019s disease","volume":"22","author":"Mao","year":"2024","journal-title":"Cell Commun Signal"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0400","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1038\/s41598-024-53102-3","article-title":"Differential functional consequences of GRIN2A mutations associated with schizophrenia and neurodevelopmental disorders","volume":"14","author":"Shepard","year":"2024","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.yebeh.2025.110421_b0405","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ng.2726","article-title":"GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction","volume":"45","author":"Lesca","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0410","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/brain\/awy304","article-title":"GRIN2A-related disorders: genotype and functional consequence predict phenotype","volume":"142","author":"Strehlow","year":"2019","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110421_b0415","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12031-021-01893-9","article-title":"Integrated bioinformatics analysis to identify alternative therapeutic targets for alzheimer\u2019s disease: insights from a synaptic machinery perspective","volume":"72","author":"Ceylan","year":"2022","journal-title":"J Mol Neurosci"},{"issue":"10","key":"10.1016\/j.yebeh.2025.110421_b0420","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/hipo.23219","article-title":"Downregulation of hyperpolarization\u2010activated cyclic nucleotide\u2010gated channels (HCN) in the hippocampus of patients with medial temporal lobe epilepsy and hippocampal sclerosis (MTLE\u2010HS)","volume":"30","author":"Lin","year":"2020","journal-title":"Hippocampus"},{"key":"10.1016\/j.yebeh.2025.110421_b0425","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.834252","article-title":"Impaired color recognition in HCN1 epilepsy: a single case report","volume":"13","author":"Mckenzie","year":"2022","journal-title":"Front Neurol"},{"issue":"12","key":"10.1016\/j.yebeh.2025.110421_b0430","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1523\/JNEUROSCI.1615-22.2022","article-title":"Retinal dysfunction in a mouse model of HCN1 genetic epilepsy","volume":"43","author":"Zhao","year":"2023","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0435","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41537-022-00271-7","article-title":"Evidence for the contribution of HCN1 gene polymorphism (rs1501357) to working memory at both behavioral and neural levels in schizophrenia patients and healthy controls","volume":"8","author":"Chen","year":"2022","journal-title":"Schizophrenia"},{"issue":"5","key":"10.1016\/j.yebeh.2025.110421_b0440","first-page":"719","article-title":"A behavioral role for dendritic integration: HCN1 channels constrain spatial memory and plasticity at inputs to distal dendrites of CA1 pyramidal neurons","volume":"119","author":"Nolan","year":"2004","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110421_b0445","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/jmedgenet-2013-102030","article-title":"NECAP1 loss of function leads to a severe infantile epileptic encephalopathy","volume":"51","author":"Alazami","year":"2014","journal-title":"J Med Genet"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110421_b0450","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/j.1471-4159.2006.04066.x","article-title":"Characterization of the localization and function of NECAP 1 in neurons","volume":"98","author":"Murshid","year":"2006","journal-title":"J Neurochem"},{"issue":"10","key":"10.1016\/j.yebeh.2025.110421_b0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001670","article-title":"NECAP 1 regulates AP-2 interactions to control vesicle size, number, and cargo during clathrin-mediated endocytosis","volume":"11","author":"Ritter","year":"2013","journal-title":"PLoS Biol"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110421_b0460","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/epi4.12263","article-title":"Confirming the pathogenicity of NECAP 1 in early onset epileptic encephalopathy","volume":"3","author":"Alsahli","year":"2018","journal-title":"Epilepsia Open"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110421_b0470","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s10038-018-0556-2","article-title":"A novel homozygous truncating variant of NECAP1 in early infantile epileptic encephalopathy: the second case report of EIEE21","volume":"64","author":"Mizuguchi","year":"2019","journal-title":"J Hum Genet"},{"issue":"9","key":"10.1016\/j.yebeh.2025.110421_b0475","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/j.1528-1167.2010.02640.x","article-title":"Sodium channel SCN1A and epilepsy: Mutations and mechanisms","volume":"51","author":"Escayg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2025.110421_b0480","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fneur.2015.00104","article-title":"Recurrent and non-recurrent mutations of SCN8A in epileptic encephalopathy","volume":"6","author":"Wagnon","year":"2015","journal-title":"Front Neurol"},{"key":"10.1016\/j.yebeh.2025.110421_b0485","doi-asserted-by":"crossref","unstructured":"Gardella E, Marini C, Trivisano M, Fitzgerald MP, Alber M, Howell KB, et al. The phenotype of SCN8A developmental and epileptic encephalopathy. Neurology [Internet]. 2018 Sep 18 [cited 2024 Nov 7];91(12). Available from: https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0000000000006199.","DOI":"10.1212\/WNL.0000000000006199"},{"issue":"s2","key":"10.1016\/j.yebeh.2025.110421_b0490","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1469-8749.2011.03966.x","article-title":"Dravet syndrome and SCN1A gene mutation related\u2010epilepsies: cognitive impairment and its determinants","volume":"53","author":"Guerrini","year":"2011","journal-title":"Develop Med Child Neuro"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110421_b0495","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/brain\/awy326","article-title":"Neuronal mechanisms of mutations in SCN8A causing epilepsy or intellectual disability","volume":"142","author":"Liu","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2025.110421_b0500","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awae167","article-title":"Scn1a haploinsufficiency in the prefrontal cortex engages to cognitive impairment and depressive phenotype","author":"Riga","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2025.110421_b0505","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.nbd.2012.12.021","article-title":"Focal Scn1a knockdown induces cognitive impairment without seizures","volume":"54","author":"Bender","year":"2013","journal-title":"Neurobiol Dis"},{"issue":"4","key":"10.1016\/j.yebeh.2025.110421_b0510","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1212\/NXG.0000000000000170","article-title":"Loss-of-function variants of SCN8A in intellectual disability without seizures","volume":"3","author":"Wagnon","year":"2017","journal-title":"Neurol Genet"},{"key":"10.1016\/j.yebeh.2025.110421_b0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2023.107266","article-title":"Inherited SCN1A missense mutation in a Dravet Syndrome family: Neuropathological correlation, family screening and implications for adult carriers","volume":"199","author":"Sierra-Marcos","year":"2024","journal-title":"Epilepsy Res"},{"issue":"6","key":"10.1016\/j.yebeh.2025.110421_b0520","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1684\/epd.2020.1221","article-title":"Benign familial infantile epilepsy associated with KCNQ3 mutation: a rare occurrence or an underestimated event?","volume":"22","author":"Nardello","year":"2020","journal-title":"Epileptic Disord"},{"issue":"9","key":"10.1016\/j.yebeh.2025.110421_b0530","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0166-2236(00)01629-5","article-title":"KCNQ2\/KCNQ3 K+ channels and the molecular pathogenesis of epilepsy: implications for therapy","volume":"23","author":"Rogawski","year":"2000","journal-title":"Trends Neurosci"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110421_b0535","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ana.26826","article-title":"De novo variants in KCNA3 cause developmental and epileptic encephalopathy","volume":"95","author":"Soldovieri","year":"2024","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110421_b0540","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejmg.2018.06.009","article-title":"Hemizygous UBA5 missense mutation unmasks recessive disorder in a patient with infantile-onset encephalopathy, acquired microcephaly, small cerebellum, movement disorder and severe neurodevelopmental delay","volume":"62","author":"Low","year":"2019","journal-title":"Eur J Med Genet"},{"issue":"5","key":"10.1016\/j.yebeh.2025.110421_b0545","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1002\/med.21719","article-title":"A multitude of signaling pathways associated with Alzheimer\u2019s disease and their roles in AD pathogenesis and therapy","volume":"41","author":"Gadhave","year":"2021","journal-title":"Med Res Rev"},{"issue":"10","key":"10.1016\/j.yebeh.2025.110421_b0550","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.cell.2024.03.015","article-title":"Human iPSC 4R tauopathy model uncovers modifiers of tau propagation","volume":"187","author":"Bravo","year":"2024","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110421_b0555","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1258\/ebm.2010.010327","article-title":"The role of the ubiquitin proteasome system in Alzheimer\u2019s disease","volume":"236","author":"Riederer","year":"2011","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.yebeh.2025.110421_b0560","article-title":"The UFMylation pathway is impaired in Alzheimer\u2019s disease","author":"Yan","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.yebeh.2025.110421_b0570","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.811686","article-title":"Neuronal ceroid lipofuscinosis: the multifaceted approach to the clinical issues, an overview","volume":"13","author":"Simonati","year":"2022","journal-title":"Front Neurol"},{"issue":"24","key":"10.1016\/j.yebeh.2025.110421_b0580","doi-asserted-by":"crossref","first-page":"13633","DOI":"10.3390\/ijms222413633","article-title":"Investigating the endo-lysosomal system in major neurocognitive disorders due to Alzheimer\u2019s disease, frontotemporal lobar degeneration and lewy body disease: Evidence for SORL1 as a cross-disease gene","volume":"22","author":"Benussi","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"S13","key":"10.1016\/j.yebeh.2025.110421_b0585","doi-asserted-by":"crossref","DOI":"10.1002\/alz.072168","article-title":"circRNAs mediate the effect of chronic lysosomal dysfunction on Alzheimer\u2019s disease pathology","volume":"19","author":"Romero","year":"2023","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1016\/j.yebeh.2025.110421_b0590","doi-asserted-by":"crossref","unstructured":"Falk MJ, Li D, Gai X, McCormick E, Place E, Lasorsa FM, et al. AGC1 Deficiency Causes Infantile Epilepsy, Abnormal Myelination, and Reduced N-Acetylaspartate. In: Zschocke J, Gibson KM, Brown G, Morava E, Peters V, editors. JIMD Reports, Volume 14 [Internet]. Berlin, Heidelberg: Springer Berlin Heidelberg; 2014 [cited 2024 Nov 7]. p. 77\u201385. (JIMD Reports; vol. 14). Available from: http:\/\/link.springer.com\/10.1007\/8904_2013_287.","DOI":"10.1007\/8904_2013_287"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0595","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00439-021-02404-x","article-title":"SLC gene mutations and pediatric neurological disorders: diverse clinical phenotypes in a Saudi Arabian population","volume":"141","author":"Mir","year":"2022","journal-title":"Hum Genet"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0600","doi-asserted-by":"crossref","first-page":"17993","DOI":"10.1038\/s41598-023-45341-7","article-title":"Assessment of expression of calcium signaling related lncRNAs in epilepsy","volume":"13","author":"Taheri","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.yebeh.2025.110421_b0605","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.conb.2019.04.008","article-title":"Emerging roles for MEF2 in brain development and mental disorders","volume":"59","author":"Assali","year":"2019","journal-title":"Curr Opin Neurobiol"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0610","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13041-021-00892-6","article-title":"Progress on the roles of MEF2C in neuropsychiatric diseases","volume":"15","author":"Zhang","year":"2022","journal-title":"Mol Brain"},{"issue":"1\u20132","key":"10.1016\/j.yebeh.2025.110421_b0615","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0169-328X(02)00519-3","article-title":"Anti-apoptotic wild-type Alzheimer amyloid precursor protein signaling involves the p38 mitogen-activated protein kinase\/MEF2 pathway","volume":"108","author":"Burton","year":"2002","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.yebeh.2025.110421_b0620","doi-asserted-by":"crossref","unstructured":"Ohori S, Miyauchi A, Osaka H, Lourenco CM, Arakaki N, Sengoku T, et al. Biallelic structural variations within FGF12 detected by long-read sequencing in epilepsy. Life Science Alliance [Internet]. 2023 [cited 2024 Nov 7];6(8). Available from: https:\/\/www.life-science-alliance.org\/content\/6\/8\/e202302025.abstract.","DOI":"10.26508\/lsa.202302025"},{"key":"10.1016\/j.yebeh.2025.110421_b0625","doi-asserted-by":"crossref","unstructured":"Saleem NM, Chencheri N, Thomas S, Alexander G, Madathil B. Early-Onset Epileptic Encephalopathy Responsive to Phenytoin: A Diagnostic Clue for Fibroblast Growth Factor 12 Mutation. Cureus [Internet]. 2024 [cited 2024 Nov 7];16(2). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC10924931\/.","DOI":"10.7759\/cureus.53906"},{"issue":"8","key":"10.1016\/j.yebeh.2025.110421_b0630","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.braindev.2018.04.002","article-title":"Two Japanese cases of epileptic encephalopathy associated with an FGF12 mutation","volume":"40","author":"Takeguchi","year":"2018","journal-title":"Brain Dev"},{"issue":"2","key":"10.1016\/j.yebeh.2025.110421_b0635","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/epi4.12396","article-title":"Epilepsy phenotype in individuals with chromosomal duplication encompassing FGF12","volume":"5","author":"Willemsen","year":"2020","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2025.110421_b0640","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.1060111","article-title":"Identification of candidate genes associated with clinical onset of Alzheimer\u2019s disease","volume":"16","author":"Liao","year":"2022","journal-title":"Front Neurosci"},{"key":"10.1016\/j.yebeh.2025.110421_b0645","first-page":"4","article-title":"Epilepsy-associated genes: an update. Seizure: European","volume":"116","author":"Zhang","year":"2024","journal-title":"J Epilepsy"},{"key":"10.1016\/j.yebeh.2025.110421_b0650","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.plipres.2016.03.006","article-title":"The enigma of ceramide synthase regulation in mammalian cells","volume":"63","author":"Wegner","year":"2016","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.yebeh.2025.110421_b0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.106922","article-title":"Identification of telomere-related genes associated with aging-related molecular clusters and the construction of a diagnostic model in Alzheimer\u2019s disease based on a bioinformatic analysis","volume":"159","author":"Ruan","year":"2023","journal-title":"Comput Biol Med"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110421_b0660","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00213-024-06530-y","article-title":"The relevance between abnormally elevated serum ceramide and cognitive impairment in Alzheimer\u2019s disease model mice and its mechanism","volume":"241","author":"Liu","year":"2024","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0665","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JAD-200964","article-title":"Cerebrospinal fluid C18 ceramide associates with markers of Alzheimer\u2019s disease and inflammation at the pre-and early stages of dementia","volume":"81","author":"Teitsdottir","year":"2021","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0670","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002482","article-title":"Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study","volume":"15","author":"Varma","year":"2018","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.yebeh.2025.110421_b0675","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3233\/JAD-161292","article-title":"A lipidomics approach to assess the association between plasma sphingolipids and verbal memory performance in coronary artery disease patients undertaking cardiac rehabilitation: A C18: 0 signature for cognitive response to exercise","volume":"60","author":"Saleem","year":"2017","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0680","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3233\/JAD-210234","article-title":"Insulin resistance as a common link between current Alzheimer\u2019s disease hypotheses","volume":"82","author":"Alves","year":"2021","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"s2","key":"10.1016\/j.yebeh.2025.110421_b0685","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-2012-111728","article-title":"Dysfunctional pro-ceramide, ER stress, and insulin\/IGF signaling networks with progression of Alzheimer\u2019s disease","volume":"30","author":"de la Monte","year":"2012","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"19","key":"10.1016\/j.yebeh.2025.110421_b0690","article-title":"The potential role of CERS1 in autophagy through PI3K\/AKT signaling pathway in hypophysoma","volume":"1","author":"Wang","year":"2020","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.yebeh.2025.110421_b0695","article-title":"Evidence of disturbed insulin signaling in animal models of Alzheimer\u2019s disease","volume":"105326","author":"Alves","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.yebeh.2025.110421_b0700","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2021.738930","article-title":"Transcriptome of the Krushinsky-Molodkina audiogenic rat strain and identification of possible audiogenic epilepsy-associated genes","volume":"14","author":"Chuvakova","year":"2021","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"10.1016\/j.yebeh.2025.110421_b0705","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/1440-1681.13326","article-title":"Evidence for altered insulin signalling in the brains of genetic absence epilepsy rats from Strasbourg","volume":"47","author":"Sekar","year":"2020","journal-title":"Clin Exp Pharma Physio"},{"issue":"10","key":"10.1016\/j.yebeh.2025.110421_b0710","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1007\/s00415-020-09937-7","article-title":"Seizures in Alzheimer\u2019s disease are highly recurrent and associated with a poor disease course","volume":"267","author":"V\u00f6glein","year":"2020","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2025.110421_b0715","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13195-023-01373-9","article-title":"Subclinical epileptiform activity in the Alzheimer continuum: association with disease, cognition and detection method","volume":"16","author":"Nous","year":"2024","journal-title":"Alz Res Therapy"},{"issue":"11","key":"10.1016\/j.yebeh.2025.110421_b0720","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamaneurol.2021.3310","article-title":"Effect of levetiracetam on cognition in patients with Alzheimer disease with and without epileptiform activity: a randomized clinical trial","volume":"78","author":"Vossel","year":"2021","journal-title":"JAMA Neurol"}],"container-title":["Epilepsy &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550502500160X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550502500160X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T17:44:43Z","timestamp":1764092683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550502500160X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":170,"alternative-id":["S152550502500160X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2025.110421","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.01.02.25319900","asserted-by":"object"}]},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transcriptomic analyses of human brains with Alzheimer\u2019s disease identified dysregulated epilepsy-causing genes","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2025.110421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110421"}}